# GRACELL BIOTECHNOLOGIES INC (GRCL)

> Institutional ownership reported to the SEC as of Q4 2023, from Form 13F filings. Source: https://holderbook.com/stocks/GRCL/

- Reporting holders: 65
- Reported value: $553.8M
- Held through calls: 0.0%
- Held through puts: 0.1%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Temasek Holdings (Private) Ltd](https://holderbook.com/funds/1021944-temasek-holdings-private-ltd/) | $96.3M | 9,588,863 | 0.5% | 12 |
| [Vivo Capital, LLC](https://holderbook.com/funds/1674712-vivo-capital-llc/) | $95.8M | 9,546,485 | 7.8% | 12 |
| [ORBIMED ADVISORS LLC](https://holderbook.com/funds/1055951-orbimed-advisors-llc/) | $93.5M | 9,308,726 | 1.9% | 12 |
| [Sio Capital Management, LLC](https://holderbook.com/funds/1482416-sio-capital-management-llc/) | $50.2M | 5,001,580 | 11.4% | 2 |
| [TCG Crossover Management, LLC](https://holderbook.com/funds/1839948-tcg-crossover-management-llc/) | $45.3M | 4,514,786 | 5.0% | 2 |
| [TANG CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/1232621-tang-capital-management-llc/) | $22.0M | 2,191,417 | 2.0% | 2 |
| [BAKER BROS. ADVISORS LP](https://holderbook.com/funds/1263508-baker-bros-advisors-lp/) | $20.9M | 2,080,000 | 0.2% | 3 |
| [Pentwater Capital Management LP](https://holderbook.com/funds/1425851-pentwater-capital-management-lp/) | $14.7M | 1,461,000 | 0.2% | 1 |
| [Pivotal bioVenture Partners Investment Advisor LLC](https://holderbook.com/funds/1844645-pivotal-bioventure-partners-investment-advisor-llc/) | $13.8M | 1,375,000 | 3.5% | 2 |
| [ADAGE CAPITAL PARTNERS GP, L.L.C.](https://holderbook.com/funds/1165408-adage-capital-partners-gp-l-l-c/) | $13.6M | 1,350,000 | 0.0% | 2 |
| [TIG Advisors, LLC](https://holderbook.com/funds/1358253-tig-advisors-llc/) | $12.8M | 1,279,595 | 1.6% | 1 |
| [ALPINE ASSOCIATES MANAGEMENT INC.](https://holderbook.com/funds/1396835-alpine-associates-management-inc/) | $12.8M | 1,278,454 | 0.7% | 1 |
| [Octagon Capital Advisors LP](https://holderbook.com/funds/1839435-octagon-capital-advisors-lp/) | $6.0M | 596,611 | 1.0% | 1 |
| [BlackRock Inc.](https://holderbook.com/funds/1364742-blackrock-inc/) | $5.4M | 539,973 | 0.0% | 12 |
| [Qube Research & Technologies Ltd](https://holderbook.com/funds/1729829-qube-research-technologies-ltd/) | $5.2M | 517,274 | 0.0% | 2 |
| [BANK OF AMERICA CORP /DE/](https://holderbook.com/funds/70858-bank-of-america-corp-de/) | $5.1M | 511,953 | 0.0% | 10 |
| [SPHERA FUNDS MANAGEMENT LTD.](https://holderbook.com/funds/1496201-sphera-funds-management-ltd/) | $5.0M | 502,936 | 0.8% | 4 |
| [MMCAP International Inc. SPC](https://holderbook.com/funds/1304857-mmcap-international-inc-spc/) | $4.5M | 451,172 | 0.8% | 1 |
| [HARVEST MANAGEMENT LLC](https://holderbook.com/funds/1140315-harvest-management-llc/) | $4.0M | 400,000 | 3.7% | 1 |
| [LMR Partners LLP](https://holderbook.com/funds/1578621-lmr-partners-llp/) | $3.3M | 510,001 | 0.0% | 4 |
| [Hudson Bay Capital Management LP](https://holderbook.com/funds/1393825-hudson-bay-capital-management-lp/) | $2.7M | 266,667 | 0.0% | 2 |
| [MARSHALL WACE, LLP](https://holderbook.com/funds/1318757-marshall-wace-llp/) | $1.9M | 192,465 | 0.0% | 3 |
| [MILLENNIUM MANAGEMENT LLC](https://holderbook.com/funds/1273087-millennium-management-llc/) | $1.9M | 191,269 | 0.0% | 2 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $1.6M | 156,238 | 0.0% | 12 |
| [AQR Arbitrage LLC](https://holderbook.com/funds/1167456-aqr-arbitrage-llc/) | $1.3M | 130,779 | 0.1% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2023 | 65 | $553.8M |
| Q3 2023 | 43 | $135.4M |
| Q2 2023 | 35 | $122.8M |
| Q1 2023 | 31 | $56.3M |
| Q4 2022 | 31 | $70.0M |
| Q3 2022 | 30 | $98.3M |
| Q2 2022 | 32 | $175.8M |
| Q1 2022 | 32 | $75.1M |
| Q4 2021 | 34 | $202.7M |
| Q3 2021 | 34 | $450.1M |
| Q2 2021 | 31 | $269.9M |
| Q1 2021 | 36 | $320.8M |